MindWalk is a Bio-Native AI company transforming drug discovery and development. MindWalk, formerly known as ImmunoPrecise Antibodies Ltd., is based in AUSTIN, Texas.
| Revenue (Most Recent Fiscal Year) | $11.24M |
| Net Income (Most Recent Fiscal Year) | $-10.11M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 5.55 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 7.33 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -99.96% |
| Net Margin (Trailing 12 Months) | -89.65% |
| Return on Equity (Trailing 12 Months) | -92.61% |
| Return on Assets (Trailing 12 Months) | -54.15% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.80 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.72 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.26 |
| Inventory Turnover (Trailing 12 Months) | 12.60 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.18 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.06 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.24 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.22 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 46.71M |
| Free Float | 43.52M |
| Market Capitalization | $62.36M |
| Average Volume (Last 20 Days) | 0.12M |
| Beta (Past 60 Months) | 0.82 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 6.83% |
| Percentage Held By Institutions (Latest 13F Reports) | 6.70% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |